Brian Patrick McNulty sold $726k of MIRA
owner at MIRA PHARMACEUTICALS, INC.. 238,095 shares at an average of $3.05, traded Nov 20, 2023, filed Dec 27, 2023.
Score components
- +12Role10% owner
- +21Trade size$726k at market
- 0Share of holdings soldSold 8.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000897069-23-001850, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2023 | SOpen-market sale Common Stockindirect: By Trust | -13,367 | $5.07 | $68k | 2,845,951 | Dec 27, 2023 |
| Nov 21, 2023 | SOpen-market sale Common Stockindirect: By Trust | -2,500 | $5.00 | $13k | 2,843,451 | Dec 27, 2023 |
| Nov 27, 2023 | SOpen-market sale Common Stockindirect: By Trust | -3,213 | $4.00 | $13k | 2,840,238 | Dec 27, 2023 |
| Nov 28, 2023 | SOpen-market sale Common Stockindirect: By Trust | -121 | $4.00 | $484 | 2,840,117 | Dec 27, 2023 |
| Nov 29, 2023 | SOpen-market sale Common Stockindirect: By Trust | -3,699 | $3.98 | $15k | 2,836,418 | Dec 27, 2023 |
| Nov 30, 2023 | SOpen-market sale Common Stockindirect: By Trust | -2,421 | $3.77 | $9,136 | 2,833,997 | Dec 27, 2023 |
| Dec 4, 2023 | SOpen-market sale Common Stockindirect: By Trust | -30,665 | $3.98 | $122k | 2,803,332 | Dec 27, 2023 |
| Dec 6, 2023 | SOpen-market sale Common Stockindirect: By Trust | -13,867 | $2.95 | $41k | 2,789,465 | Dec 27, 2023 |
| Dec 7, 2023 | SOpen-market sale Common Stockindirect: By Trust | -16,666 | $1.89 | $32k | 2,772,799 | Dec 27, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stockindirect: By Trust | -9,526 | $1.61 | $15k | 2,763,273 | Dec 27, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: By Trust | -23,003 | $1.55 | $36k | 2,740,270 | Dec 27, 2023 |
| Nov 20, 2023 | SOpen-market sale Common Stockindirect: By Trust | -13,366 | $5.07 | $68k | 765,681 | Dec 27, 2023 |
| Nov 21, 2023 | SOpen-market sale Common Stockindirect: By Trust | -2,500 | $5.00 | $13k | 763,181 | Dec 27, 2023 |
| Nov 27, 2023 | SOpen-market sale Common Stockindirect: By Trust | -3,212 | $4.00 | $13k | 759,969 | Dec 27, 2023 |
| Nov 28, 2023 | SOpen-market sale Common Stockindirect: By Trust | -120 | $4.00 | $480 | 759,849 | Dec 27, 2023 |
| Nov 29, 2023 | SOpen-market sale Common Stockindirect: By Trust | -3,700 | $3.98 | $15k | 756,149 | Dec 27, 2023 |
| Nov 30, 2023 | SOpen-market sale Common Stockindirect: By Trust | -2,421 | $3.77 | $9,136 | 753,728 | Dec 27, 2023 |
| Dec 4, 2023 | SOpen-market sale Common Stockindirect: By Trust | -30,666 | $3.98 | $122k | 723,062 | Dec 27, 2023 |
| Dec 6, 2023 | SOpen-market sale Common Stockindirect: By Trust | -13,866 | $2.95 | $41k | 709,196 | Dec 27, 2023 |
| Dec 7, 2023 | SOpen-market sale Common Stockindirect: By Trust | -16,667 | $1.89 | $32k | 692,529 | Dec 27, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stockindirect: By Trust | -9,527 | $1.61 | $15k | 683,002 | Dec 27, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: By Trust | -23,002 | $1.55 | $36k | 660,000 | Dec 27, 2023 |
Related signals
Other insiders at MIRA PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 16Weak | MIRA PHARMACEUTICALS, INC. | Erez Aminov Chief Executive Officer | $134k 100,000 shares | -9% | |
| 28Weak | MIRAsell MIRA PHARMACEUTICALS, INC. | Brian Patrick McNulty owner | $392k 200,000 shares | -7% | |
| 33Weak | MIRAbuy MIRA PHARMACEUTICALS, INC. | Erez Aminov Chief Executive Officer | $8,176 8,700 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.